var data={"title":"Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Clinical features, evaluation, and diagnosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Clinical features, evaluation, and diagnosis</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Irl B Hirsch, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Michael Emmett, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">David M Nathan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Jean E Mulder, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Dec 07, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS, also known as hyperosmotic hyperglycemic nonketotic state [HHNK]) are two of the most serious acute complications of diabetes. DKA is characterized by ketoacidosis and hyperglycemia, while HHS usually has more severe hyperglycemia but no ketoacidosis (<a href=\"image.htm?imageKey=ENDO%2F72111\" class=\"graphic graphic_table graphicRef72111 \">table 1</a>). Each represents an extreme in the spectrum of hyperglycemia.</p><p>The precipitating factors, clinical features, evaluation, and diagnosis of DKA and HHS in adults will be reviewed here. The epidemiology, pathogenesis, and treatment of these disorders are discussed separately. DKA in children is also reviewed separately.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-epidemiology-and-pathogenesis\" class=\"medical medical_review\">&quot;Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Epidemiology and pathogenesis&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-treatment\" class=\"medical medical_review\">&quot;Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Treatment&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-diabetic-ketoacidosis-in-children-and-adolescents\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of diabetic ketoacidosis in children and adolescents&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=treatment-and-complications-of-diabetic-ketoacidosis-in-children-and-adolescents\" class=\"medical medical_review\">&quot;Treatment and complications of diabetic ketoacidosis in children and adolescents&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">PRECIPITATING FACTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A precipitating event can usually be identified in patients with diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS) (<a href=\"image.htm?imageKey=PC%2F64374\" class=\"graphic graphic_table graphicRef64374 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/1-3\" class=\"abstract_t\">1-3</a>]. The most common events are infection (often pneumonia or urinary tract infection) and discontinuation of or inadequate insulin therapy. Compromised water intake due to underlying medical conditions, particularly in older patients, can promote the development of severe dehydration and HHS [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/3-5\" class=\"abstract_t\">3-5</a>].</p><p>Other conditions and factors associated with DKA and HHS include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acute major illnesses such as myocardial infarction, cerebrovascular accident, sepsis, or pancreatitis.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>New onset type 1 diabetes, in which DKA is a common presentation.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In established type 1 diabetes, omission of insulin in setting of gastroenteritis when patient mistakenly stops insulin because of reduced oral intake.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Drugs that affect carbohydrate metabolism, including glucocorticoids, higher-dose thiazide diuretics, sympathomimetic agents (eg, <a href=\"topic.htm?path=dobutamine-drug-information\" class=\"drug drug_general\">dobutamine</a> and <a href=\"topic.htm?path=terbutaline-drug-information\" class=\"drug drug_general\">terbutaline</a>) [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/6\" class=\"abstract_t\">6</a>], and second-generation &ldquo;atypical&rdquo; antipsychotic agents [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/7\" class=\"abstract_t\">7</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>SGLT2 inhibitors, mostly used in type 2 diabetes but also used off-label in type 1 diabetes. There is a complex physiology that has resulted in reports of DKA in both types of diabetes [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/8\" class=\"abstract_t\">8</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cocaine use, which has been associated with recurrent DKA [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/9,10\" class=\"abstract_t\">9,10</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Psychological problems associated with eating disorders and purposeful insulin omission, particularly in young patients with type 1 diabetes [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/11\" class=\"abstract_t\">11</a>]. Factors that may lead to insulin omission in younger patients include fear of weight gain, fear of hypoglycemia, rebellion from authority, and the stress of chronic disease.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Poor compliance with the insulin regimen.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Malfunction of continuous subcutaneous insulin infusion devices (CSII), which was initially reported in the early 1980s [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/12\" class=\"abstract_t\">12</a>]. Pump malfunction is now uncommon, but system failure due to blockage or leakage in the syringe or the infusion set or connectors, causing an interruption of infusion flow, can lead to DKA. The frequency of DKA with pump therapy, however, appears to be no different from that with multiple daily injections of insulin [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/13\" class=\"abstract_t\">13</a>].</p><p/><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">CLINICAL PRESENTATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Diabetic ketoacidosis (DKA) usually evolves rapidly, over a 24-hour period. In contrast, symptoms of hyperosmolar hyperglycemic state (HHS) develop more insidiously with polyuria, polydipsia, and weight loss, often persisting for several days before hospital admission.</p><p>The earliest symptoms of marked hyperglycemia are polyuria, polydipsia, and weight loss. As the degree or duration of hyperglycemia progresses, neurologic symptoms, including lethargy, focal signs, and obtundation, can develop. This can progress to coma in later stages. Neurologic symptoms are most common in HHS, while hyperventilation and abdominal pain are primarily limited to patients with DKA.</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Neurologic symptoms</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neurologic deterioration primarily occurs in patients with an effective plasma osmolality above 320 to 330 <span class=\"nowrap\">mosmol/kg</span> [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/1,14-16\" class=\"abstract_t\">1,14-16</a>] (see <a href=\"#H4564954\" class=\"local\">'Plasma osmolality'</a> below). Mental obtundation and coma are more frequent in HHS than DKA because of the usually greater degree of hyperosmolality in HHS (<a href=\"image.htm?imageKey=ENDO%2F72111\" class=\"graphic graphic_table graphicRef72111 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/17\" class=\"abstract_t\">17</a>]. In addition, some patients with HHS have focal neurologic signs (hemiparesis or hemianopsia) <span class=\"nowrap\">and/or</span> seizures [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/17-21\" class=\"abstract_t\">17-21</a>]. Mental obtundation may occur in patients with DKA, who have lesser degrees of hyperosmolality, when severe acidosis exists [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/22\" class=\"abstract_t\">22</a>]. However, stupor or coma in diabetic patients with an effective plasma osmolality lower than 320 <span class=\"nowrap\">mosmol/kg</span> demands immediate consideration of other causes of the mental status change.</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Abdominal pain in DKA</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with DKA may present with nausea, vomiting, and abdominal pain; although more common in children, these symptoms can be seen in adults [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/23\" class=\"abstract_t\">23</a>]. Abdominal pain is unusual in HHS. In a review of 189 consecutive episodes of DKA and 11 episodes of HHS, abdominal pain was reported in 46 percent of patients with DKA compared with none of the patients with HHS [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/24\" class=\"abstract_t\">24</a>]. Abdominal pain was associated with the severity of the metabolic acidosis (occurring in 86 percent of those with a serum bicarbonate &le;5 but only 13 percent of those with a serum bicarbonate &ge;15 <span class=\"nowrap\">mEq/L)</span> but did not correlate with the severity of hyperglycemia or dehydration.</p><p>Possible causes of abdominal pain include delayed gastric emptying and ileus induced by the metabolic acidosis and associated electrolyte abnormalities [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. Other causes for abdominal pain, such as pancreatitis, should be sought when they occur in the absence of severe metabolic acidosis and when they persist after the resolution of ketoacidosis.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Physical examination</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Signs of volume depletion are common in both DKA and HHS and include decreased skin turgor, dry axillae and oral mucosa, low jugular venous pressure, tachycardia, and, if severe, hypotension. Neurologic findings, noted above, also may be seen, particularly in patients with HHS. (See <a href=\"#H6\" class=\"local\">'Neurologic symptoms'</a> above and <a href=\"topic.htm?path=etiology-clinical-manifestations-and-diagnosis-of-volume-depletion-in-adults\" class=\"medical medical_review\">&quot;Etiology, clinical manifestations, and diagnosis of volume depletion in adults&quot;</a>.)</p><p>Patients with DKA may have a fruity odor (due to exhaled acetone; this is similar to the scent of nail polish remover) and deep respirations reflecting the compensatory hyperventilation (called Kussmaul respirations).</p><p class=\"headingAnchor\" id=\"H6003656\"><span class=\"h1\">DIAGNOSTIC EVALUATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Both diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are medical emergencies that require prompt recognition and management (<a href=\"image.htm?imageKey=EM%2F57723\" class=\"graphic graphic_table graphicRef57723 \">table 3</a>). </p><p class=\"headingAnchor\" id=\"H6004079\"><span class=\"h2\">Initial evaluation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The initial evaluation of patients with hyperglycemic crises should include assessment of cardiorespiratory status, volume status, and mental status. The initial history and rapid but careful physical examination should focus on:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Airway, breathing, and circulation (ABC) status</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mental status</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Possible precipitating events (eg, source of infection, myocardial infarction)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Volume status</p><p/><p>The initial laboratory evaluation of a patient with suspected DKA or HHS should include determination of:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serum glucose</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serum electrolytes (with calculation of the anion gap), blood urea nitrogen (BUN), and plasma creatinine</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Complete blood count (CBC) with differential</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Urinalysis and urine ketones by dipstick</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Plasma osmolality</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serum ketones (if urine ketones are present)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Arterial blood gas if the serum bicarbonate is substantially reduced or hypoxia is suspected</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Electrocardiogram</p><p/><p>Additional testing, such as cultures of urine, sputum, and blood, serum lipase and amylase, and chest radiograph should be performed on a case-by-case basis. Infection (most commonly pneumonia and urinary tract infection) is a common precipitating event. Thus, cultures should be obtained if there are suggestive clinical findings. Recognize that infection may exist in the absence of fever in these patients [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/25-27\" class=\"abstract_t\">25-27</a>].</p><p>Measurement of glycated hemoglobin (A1C) may be useful in determining whether the acute episode is the culmination of an evolutionary process in previously undiagnosed or poorly controlled diabetes or a truly acute episode in an otherwise well-controlled patient.</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Laboratory findings</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hyperglycemia and hyperosmolality are the two primary laboratory findings in patients with DKA or HHS; patients with DKA also have a high anion gap metabolic acidosis (<a href=\"image.htm?imageKey=ENDO%2F72111\" class=\"graphic graphic_table graphicRef72111 \">table 1</a>).</p><p>A variety of other laboratory tests may be affected. The impact of hyperglycemia, insulin deficiency, osmotic diuresis, and fluid intake in each individual patient leads to variable laboratory findings, depending upon the relative importance of these factors.</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">Serum glucose</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The serum glucose concentration frequently exceeds 1000 <span class=\"nowrap\">mg/dL</span> (56 <span class=\"nowrap\">mmol/L)</span> in HHS [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/14,28\" class=\"abstract_t\">14,28</a>], but is generally less than 800 <span class=\"nowrap\">mg/dL</span> (44 <span class=\"nowrap\">mmol/L)</span> and often approximately 350 to 500 <span class=\"nowrap\">mg/dL</span> (19.4 to 27.8 <span class=\"nowrap\">mmol/L)</span> in DKA [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/15,28\" class=\"abstract_t\">15,28</a>]. Euglycemic DKA, in which the serum glucose is normal or near normal, has been described, particularly in patients with poor oral intake, treatment with insulin prior to arrival in the emergency department, or in pregnant women [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/29-31\" class=\"abstract_t\">29-31</a>]. </p><p>Euglycemic or minimally hyperglycemic diabetic ketoacidosis has also been described in patients treated with the class of drugs that block the <span class=\"nowrap\">sodium/glucose</span> cotransporter 2 (SGLT2 inhibitors). The glucosuria these drugs produce can minimize or block the development of hyperglycemia when insulin <span class=\"nowrap\">levels/activity</span> are too low to prevent the development of ketoacidosis. SGLT2 inhibitors and their adverse effects are reviewed in detail elsewhere. (See <a href=\"topic.htm?path=sodium-glucose-co-transporter-2-inhibitors-for-the-treatment-of-type-2-diabetes-mellitus#H2627189083\" class=\"medical medical_review\">&quot;Sodium-glucose co-transporter 2 inhibitors for the treatment of type 2 diabetes mellitus&quot;, section on 'Diabetic ketoacidosis'</a>.)</p><p>Patients with euglycemic diabetic ketoacidosis generally require both insulin and glucose to reverse the ketoacidosis. (See <a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-treatment#H8\" class=\"medical medical_review\">&quot;Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Treatment&quot;, section on 'Fluid replacement'</a> and <a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-treatment#H10\" class=\"medical medical_review\">&quot;Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Treatment&quot;, section on 'Insulin'</a>.)</p><p>The mechanism underlying the hyperglycemia in DKA and HHS is reviewed in detail separately. (See <a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-epidemiology-and-pathogenesis#H7\" class=\"medical medical_review\">&quot;Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Epidemiology and pathogenesis&quot;, section on 'Hyperglycemia'</a>.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h3\">Serum ketones</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Three ketone bodies are produced and accumulate in DKA: acetoacetic acid, which is the only one that is a true ketoacid; beta-hydroxybutyric acid (a hydroxyacid formed by the reduction of acetoacetic acid); and acetone, which is derived from the decarboxylation of acetoacetic acid. Acetone is a true ketone, not an acid. Testing for serum ketones is generally performed if urine testing is positive. Urine ketone bodies are detected with <a href=\"topic.htm?path=nitroprusside-drug-information\" class=\"drug drug_general\">nitroprusside</a> tests, while serum ketones can be detected with either a nitroprusside test or by direct assay of beta-hydroxybutyrate levels. Direct assay of beta-hydroxybutyrate levels is preferred, particularly for monitoring response to therapy. (See <a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-treatment#H23160657\" class=\"medical medical_review\">&quot;Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Treatment&quot;, section on 'Monitoring'</a>.)</p><p class=\"headingAnchor\" id=\"H3174363\"><span class=\"h4\">Nitroprusside testing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>This chemical develops a purple color in the presence of acetoacetic acid (and to a much lesser degree, acetone). Urine dipstick testing with <a href=\"topic.htm?path=nitroprusside-drug-information\" class=\"drug drug_general\">nitroprusside</a> tablets (Acetest) or reagent sticks (Ketostix) is widely utilized and results are available within minutes. Serum testing is necessary to determine if serum ketone levels can explain the high anion gap acidosis. A 4+ reaction with serum diluted 1:1 is highly suggestive of ketoacidosis. A 4+ reaction in more diluted serum (ie, 1:4, 1:8, etc) provides evidence of even higher concentrations of acetoacetic acid. Although one cannot directly extrapolate from the nitroprusside result to the severity of the acidosis or the magnitude of the anion gap, this is a useful semiquantitative test for the evaluation of possible ketoacidosis. Although the nitroprusside reaction is still widely used to detect ketone bodies in urine, its use for serum testing has become uncommon. Both false-negative and false-positive results should be considered.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>False-negative </strong><a href=\"topic.htm?path=nitroprusside-drug-information\" class=\"drug drug_general\">nitroprusside</a><strong> testing</strong> &ndash; The fact that nitroprusside reacts with acetoacetate and, to a lesser degree, acetone (which is not an acid), but not<strong> </strong>with beta-hydroxybutyrate,<strong> </strong>can cause diagnostic confusion. This is important because beta-hydroxybutyrate can become the predominant ketone, particularly in severe DKA. The ratio of beta-hydroxybutyrate to acetoacetate, which is about 1:1 in normal subjects, can increase to as high as 10:1 in DKA [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/32\" class=\"abstract_t\">32</a>]. This ratio also increases when lactic acidosis coexists with ketoacidosis. It is therefore possible, although unusual, to have a negative serum nitroprusside reaction in the presence of severe ketosis.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>False-positive </strong><a href=\"topic.htm?path=nitroprusside-drug-information\" class=\"drug drug_general\">nitroprusside</a><strong> testing</strong> &ndash; False-positive nitroprusside urine ketone results can be generated by drugs containing free sulfhydryl groups that react with nitroprusside. <a href=\"topic.htm?path=captopril-drug-information\" class=\"drug drug_general\">Captopril</a>, <a href=\"topic.htm?path=penicillamine-drug-information\" class=\"drug drug_general\">penicillamine</a>, and <a href=\"topic.htm?path=mesna-drug-information\" class=\"drug drug_general\">mesna</a> are several drugs with this property.</p><p/><p class=\"headingAnchor\" id=\"H3174381\"><span class=\"h4\">Direct measurement of serum beta-hydroxybutyrate</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For a number of reasons, including the problems described above, the serum <a href=\"topic.htm?path=nitroprusside-drug-information\" class=\"drug drug_general\">nitroprusside</a> test for ketone bodies has been largely replaced by direct assays for beta-hydroxybutyrate [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/33\" class=\"abstract_t\">33</a>]. Several beta-hydroxybutyrate assay instruments are commercially available [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/32,34-36\" class=\"abstract_t\">32,34-36</a>]. Direct assays for serum beta-hydroxybutyrate will eliminate the problems associated with nitroprusside testing. One limitation of some of these assays is that beta-hydroxybutyrate cannot be quantitated above a level of 6 <span class=\"nowrap\">mEq/L</span>. An ideal assay for &quot;ketoacids&quot; would measure the concentrations of both acetoacetate and beta-hydroxybutyrate.</p><p>Point-of-care bedside analyzers to measure capillary blood beta-hydroxybutyrate are becoming increasingly available [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/37,38\" class=\"abstract_t\">37,38</a>].</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h3\">Anion gap metabolic acidosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The serum anion gap is calculated as follows:</p><p>Serum anion gap = Serum sodium - (serum chloride + bicarbonate)</p><p>By convention, it is the actual measured plasma sodium concentration and not the sodium concentration corrected for the simultaneous glucose concentration that is used for this calculation.</p><p>The serum bicarbonate concentration in DKA is usually moderately-to-markedly reduced. In contrast, the serum bicarbonate concentration is normal or only mildly reduced in HHS (<a href=\"image.htm?imageKey=ENDO%2F72111\" class=\"graphic graphic_table graphicRef72111 \">table 1</a>). Patients with DKA usually present with a serum anion gap greater than 20 <span class=\"nowrap\">mEq/L</span> (normal range approximately 3 to 10 <span class=\"nowrap\">mEq/L)</span>. In patients with DKA, the elevated anion gap metabolic acidosis is caused by the accumulation of beta-hydroxybutyric and acetoacetic acids. However, the increase in anion gap is variable, being determined by several factors: the rate and duration of ketoacid production, the rate of metabolism of the ketoacids and their loss in the urine, and the volume of distribution of the ketoacid anions. (See <a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-epidemiology-and-pathogenesis#H4633831\" class=\"medical medical_review\">&quot;Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Epidemiology and pathogenesis&quot;, section on 'Anion gap metabolic acidosis'</a>.)</p><p>Compensatory hyperventilation reduces the partial pressure of carbon dioxide (CO2) and mitigates the fall in arterial pH. However, severe ketoacidosis can reduce the pH below 7.0, especially if hyperventilation is compromised.</p><p class=\"headingAnchor\" id=\"H4564954\"><span class=\"h3\">Plasma osmolality</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Plasma osmolality is always elevated in patients with HHS but less so with DKA (<a href=\"image.htm?imageKey=ENDO%2F72111\" class=\"graphic graphic_table graphicRef72111 \">table 1</a>). The typical total body deficits of water and electrolytes in DKA and HHS are compared in a table (<a href=\"image.htm?imageKey=ENDO%2F76060\" class=\"graphic graphic_table graphicRef76060 \">table 4</a>). In patients with HHS, the effective plasma osmolality is typically &gt;320 <span class=\"nowrap\">mosm/kg</span>.</p><p>Effective plasma osmolality (Posm, in <span class=\"nowrap\">mosmol/kg)</span> is the portion of total osmolality which is generated by sodium salts and glucose (and if present, <a href=\"topic.htm?path=mannitol-drug-information\" class=\"drug drug_general\">mannitol</a> or sucrose). Effective osmoles do not penetrate most cell membranes and can cause movement of water across membranes to achieve osmolal equilibrium. Effective plasma osmolality does not include &quot;ineffective&quot; osmoles, such as urea, because urea is rapidly permeable across most cell membranes and its accumulation does not induce major water shifts between the intracellular spaces (including the brain) and the extracellular water space [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/39\" class=\"abstract_t\">39</a>].</p><p>Effective osmolality can be estimated with either of the following equations, depending upon the units for sodium (Na) and glucose:</p><p class=\"bulletIndent1\">Effective Posm = [2 x Na <span class=\"nowrap\">(mEq/L)]</span> + [glucose <span class=\"nowrap\">(mg/dL)</span> &divide; 18]</p><p/><p class=\"bulletIndent1\">Effective Posm = [2 x Na <span class=\"nowrap\">(mmol/L)]</span> + glucose <span class=\"nowrap\">(mmol/L)</span></p><p/><p>The Na is the actual measured plasma sodium concentration and not the corrected sodium concentration. The Na is multiplied by two to account for the osmotic contribution of sodium&rsquo;s accompanying anions (primarily chloride and bicarbonate). Eighteen is a factor to convert glucose units from <span class=\"nowrap\">mg/dL</span> into <span class=\"nowrap\">mmol/L</span>.</p><p>If the plasma osmolality is measured, using a freezing point reduction osmometer, the result is the total osmolality. Because effective osmolality excludes urea osmoles (BUN), it can be estimated as:</p><p class=\"bulletIndent1\">Effective Posm = Measured Posm - [BUN <span class=\"nowrap\">(mg/dL)</span> &divide; 2.8]</p><p/><p class=\"bulletIndent1\">Effective Posm = Measured Posm - BUN <span class=\"nowrap\">(mmol/L)</span></p><p/><p>2.8 is a factor to convert urea concentration from units of <span class=\"nowrap\">mg/dL</span> into <span class=\"nowrap\">mmol/L</span>.</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h3\">Serum sodium</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most patients with DKA and HHS are mildly hyponatremic [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/40\" class=\"abstract_t\">40</a>]. However, patients with HHS who have a marked osmotic diuresis may present with a normal or even elevated serum sodium concentration, despite a markedly elevated serum glucose concentration that can exceed 1000 <span class=\"nowrap\">mg/dL</span> (56 <span class=\"nowrap\">mmol/L)</span> [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/41\" class=\"abstract_t\">41</a>]. These patients have a markedly elevated effective plasma osmolality and often have neurologic symptoms that can include seizures and coma (see <a href=\"#H6\" class=\"local\">'Neurologic symptoms'</a> above). Inadequate water intake contributes to the hyperosmolality and is a particular problem in hot weather and in older individuals who may have an impaired thirst mechanism [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/42\" class=\"abstract_t\">42</a>].</p><p>The measured serum sodium concentration in uncontrolled diabetes mellitus is variable because of the interaction of multiple factors, some lower sodium concentration and others that raise it. The increase in plasma osmolality created by hyperglycemia pulls water out of the cells, and this reduces the plasma sodium (Na) concentration. Physiologic calculations suggest that, in the absence of urine losses, the serum sodium concentration should fall by about 1.6 <span class=\"nowrap\">mEq/L</span> for each 100 <span class=\"nowrap\">mg/100</span> mL (5.5 <span class=\"nowrap\">mmol/L)</span> increase in glucose concentration. We use a simple <span class=\"nowrap\">&Delta;Na/&Delta;Glucose</span> concentration ratio of 2.0 <span class=\"nowrap\">mEq/L</span> decline in Na for each 100 <span class=\"nowrap\">mg/100</span> mL (5.5 <span class=\"nowrap\">mmol/L)</span> increase in glucose concentration. The &quot;corrected&quot; sodium concentration can then be approximated by adding 2.0 <span class=\"nowrap\">mEq/L</span> to the plasma sodium concentration for each 100 <span class=\"nowrap\">mg/100</span> mL (5.5 <span class=\"nowrap\">mmol/L)</span> increase above normal in glucose concentration (<a href=\"topic.htm?path=calculator-plasma-sodium-concentration-correction-for-hyperglycemia\" class=\"calc calc_professional\">calculator 1</a>). (See <a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-epidemiology-and-pathogenesis#H4634824\" class=\"medical medical_review\">&quot;Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Epidemiology and pathogenesis&quot;, section on 'Plasma osmolality and sodium'</a> and <a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-treatment#H8\" class=\"medical medical_review\">&quot;Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Treatment&quot;, section on 'Fluid replacement'</a>.)</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h4\">Pseudohyponatremia/pseudohyperchloremia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Some patients with uncontrolled diabetes develop marked hyperlipidemia and have lactescent serum. This can create electrolyte artifacts when certain analyzers are utilized. Hyperlipidemia will displace water and thereby reduce the plasma water phase fraction below its normal 93 percent. If any step in the analysis requires an exact volume of plasma (or serum), then a reduced amount of water (and electrolyte) will be analyzed. This can result in &ldquo;pseudohyponatremia.&rdquo; This artifact occurs with any flame photometric analysis and most indirect potentiometric or ion selective electrode methods. However, direct potentiometry analytical methods are generally not susceptible to this artifact [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/43-45\" class=\"abstract_t\">43-45</a>]. (See <a href=\"topic.htm?path=diagnostic-evaluation-of-adults-with-hyponatremia\" class=\"medical medical_review\">&quot;Diagnostic evaluation of adults with hyponatremia&quot;</a>.)</p><p>However, hyperlipemia can have an opposite artifactual effect on the chloride concentration when certain chloride analyzers are employed, generating marked pseudohyperchloremia [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/46\" class=\"abstract_t\">46</a>]. (See <a href=\"topic.htm?path=serum-anion-gap-in-conditions-other-than-metabolic-acidosis#H4\" class=\"medical medical_review\">&quot;Serum anion gap in conditions other than metabolic acidosis&quot;, section on 'Negative serum anion gap'</a>.)</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h3\">Serum potassium</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients presenting with DKA or HHS have a potassium deficit that averages 300 to 600 mEq (<a href=\"image.htm?imageKey=ENDO%2F76060\" class=\"graphic graphic_table graphicRef76060 \">table 4</a>) [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/40,47,48\" class=\"abstract_t\">40,47,48</a>]. A number of factors contribute to this deficit, particularly increased urinary losses due both to the glucose osmotic diuresis and to the excretion of potassium ketoacid anion salts. Despite these total body potassium deficits, hypokalemia is observed in only approximately 5 percent of cases [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/49,50\" class=\"abstract_t\">49,50</a>]. The serum potassium concentration is usually normal or, in one-third of patients, elevated on admission [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/28,40,51\" class=\"abstract_t\">28,40,51</a>]. This is mainly due to a shift of potassium from intracellular fluid to extracellular fluid caused by hyperosmolality and insulin deficiency [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/6,39,40\" class=\"abstract_t\">6,39,40</a>]. (See <a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-epidemiology-and-pathogenesis#H3175204\" class=\"medical medical_review\">&quot;Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Epidemiology and pathogenesis&quot;, section on 'Potassium'</a>.)</p><p>Insulin therapy shifts potassium into cells and lowers the potassium concentration. This may cause severe hypokalemia, particularly in patients who present with a normal or low serum potassium concentration [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/48\" class=\"abstract_t\">48</a>]. Careful monitoring and timely administration of potassium supplementation are essential. (See <a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-treatment#H10738776\" class=\"medical medical_review\">&quot;Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Treatment&quot;, section on 'Potassium replacement'</a>.)</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h3\">Serum phosphate</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with uncontrolled hyperglycemia are typically in negative phosphate balance because of decreased phosphate intake, an acidosis-related shift of phosphate into the extracellular fluid (ECF) when metabolic acidosis exists, and phosphaturia caused by osmotic diuresis. Despite phosphate depletion, the serum phosphate concentration at presentation is usually normal or even high because both insulin deficiency and metabolic acidosis cause a shift of phosphate out of the cells and as a result of ECF volume contraction [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/52,53\" class=\"abstract_t\">52,53</a>].</p><p>This transcellular shift is reversed and the true state of phosphate balance is unmasked after treatment with insulin and volume expansion. In a review of 69 episodes of DKA, the mean serum phosphate concentration fell from 9.2 <span class=\"nowrap\">mg/dL</span> (3 <span class=\"nowrap\">mmol/L)</span> at presentation to 2.8 <span class=\"nowrap\">mg/dL</span> (0.9 <span class=\"nowrap\">mmol/L)</span> at 12 hours, and in some patients to levels as low as 1.0 <span class=\"nowrap\">mg/dL</span> (0.32 <span class=\"nowrap\">mmol/L)</span> [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/52\" class=\"abstract_t\">52</a>]. (See <a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-treatment#H19\" class=\"medical medical_review\">&quot;Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Treatment&quot;, section on 'Phosphate depletion'</a>.)</p><p class=\"headingAnchor\" id=\"H3174624\"><span class=\"h3\">Serum creatinine</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most patients with uncontrolled hyperglycemia have acute elevations in the BUN and serum creatinine concentration, which reflect the reduction in glomerular filtration rate induced by hypovolemia. High acetoacetate levels can also artifactually increase serum creatinine levels when certain colorimetric assays are utilized [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/54\" class=\"abstract_t\">54</a>]. However, most laboratories now utilize enzymatic assays which are not affected by this artifact [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/55\" class=\"abstract_t\">55</a>].</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h3\">Serum amylase and lipase</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute pancreatitis may precipitate or complicate DKA. Serum amylase and lipase are generally used to diagnose acute pancreatitis, but each of these enzymes is often elevated in patients with DKA who do not have any other clinical or radiological evidence of pancreatitis [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/56-60\" class=\"abstract_t\">56-60</a>]. Therefore, the diagnosis of pancreatitis in patients with DKA should be primarily based upon clinical findings and imaging. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-pancreatitis#H14\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of acute pancreatitis&quot;, section on 'Imaging'</a>.)</p><p>The mechanisms for non-pancreatitis associated hyperamylasemia and hyperlipasemia in DKA are not well understood, but the following observations have been made:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a review of 134 consecutive episodes of DKA in patients without evidence of acute pancreatitis on computed tomography (CT) scan, elevations of serum amylase and lipase (threefold or higher in some patients) were seen in 17 and 24 percent, respectively [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/56\" class=\"abstract_t\">56</a>]. Abdominal pain was present in 19 percent of the patients in this series.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The source of these nonspecific amylase elevations is most often salivary, though some may also be of pancreatic origin [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/57,58,60\" class=\"abstract_t\">57,58,60</a>]. The source of nonspecific lipase elevations is not known.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The rise in amylase correlates with pH and plasma osmolality, while the rise in lipase correlates only with plasma osmolality [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/56\" class=\"abstract_t\">56</a>]. Values peak within 24 hours of presentation [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/60\" class=\"abstract_t\">60</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In 100 consecutive cases of DKA, 11 did have acute pancreatitis confirmed by CT scan. The most common causes of pancreatitis in these patients were hypertriglyceridemia and chronic alcohol intake [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/61\" class=\"abstract_t\">61</a>]. Two of the 10 evaluable patients (one was comatose) did not have abdominal pain.</p><p/><p class=\"headingAnchor\" id=\"H21\"><span class=\"h3\">Leukocytosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The majority of patients with hyperglycemic emergencies present with leukocytosis, which is proportional to the degree of ketonemia [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/6,62\" class=\"abstract_t\">6,62</a>]. Leukocytosis unrelated to infection may occur as a result of hypercortisolemia and increased catecholamine secretion [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/63\" class=\"abstract_t\">63</a>]. However, a white blood cell count greater than <span class=\"nowrap\">25,000/microL</span> or more than 10 percent bands increases suspicion for infection and should be evaluated [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/64\" class=\"abstract_t\">64</a>].</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h3\">Lipids</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with DKA or HHS may present with marked hyperlipidemia and lactescent serum. In a study of 13 patients with DKA, the mean plasma triglyceride and cholesterol levels on admission were 574 <span class=\"nowrap\">mg/dL</span> (6.5 <span class=\"nowrap\">mmol/L)</span> and 212 <span class=\"nowrap\">mg/dL</span> (5.5 <span class=\"nowrap\">mmol/L),</span> respectively [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/65\" class=\"abstract_t\">65</a>]. Triglycerides fell below 150 <span class=\"nowrap\">mg/dL</span> (1.7 <span class=\"nowrap\">mmol/L)</span> in 24 hours with insulin therapy.</p><p>Lipolysis in DKA, and to a lesser extent in HHS, is due to insulin deficiency, combined with elevated levels of lipolytic hormones (catecholamines, growth hormone, corticotropin [ACTH], and glucagon). Lipolysis releases glycerol and free fatty acids into the circulation. High levels of serum fatty acids inhibit glycolysis, and in the hepatocyte mitochondria is the substrate for ketoacid generation. Insulin is the most potent anti-lipolytic hormone.</p><p class=\"headingAnchor\" id=\"H5509770\"><span class=\"h1\">DIAGNOSTIC CRITERIA</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are distinguished by the absence of ketoacidosis and usually greater degree of hyperglycemia in HHS [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/25,28,66\" class=\"abstract_t\">25,28,66</a>]. The diagnostic criteria proposed by the American Diabetes Association (ADA) for mild, moderate, and severe DKA and HHS are shown in the table (<a href=\"image.htm?imageKey=ENDO%2F72111\" class=\"graphic graphic_table graphicRef72111 \">table 1</a>).</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>DKA is characterized by the triad of hyperglycemia, anion gap metabolic acidosis, and ketonemia. Metabolic acidosis is often the major finding. The serum glucose concentration is usually less than 800 <span class=\"nowrap\">mg/dL</span> (44 <span class=\"nowrap\">mmol/L)</span> and often approximately 350 to 500 <span class=\"nowrap\">mg/dL</span> (19.4 to 27.8 <span class=\"nowrap\">mmol/L)</span> [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/15,28\" class=\"abstract_t\">15,28</a>]. However, serum glucose concentrations may exceed 900 <span class=\"nowrap\">mg/dL</span> (50 <span class=\"nowrap\">mmol/L)</span> in patients with DKA who are comatose [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/67\" class=\"abstract_t\">67</a>]. In certain settings, such as starvation, pregnancy, treatment with insulin prior to arrival in the emergency department, or use of SGLT2 inhibitors, the glucose level may be only mildly elevated.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In HHS, there is little or no ketoacid accumulation, the serum glucose concentration frequently exceeds 1000 <span class=\"nowrap\">mg/dL</span> (56 <span class=\"nowrap\">mmol/L),</span> the plasma osmolality may reach 380 <span class=\"nowrap\">mosmol/kg,</span> and neurologic abnormalities are frequently present (including coma in 25 to 50 percent of cases) [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/14,25,28\" class=\"abstract_t\">14,25,28</a>]. Most patients with HHS have an admission pH &gt;7.30, a serum bicarbonate &gt;20 <span class=\"nowrap\">mEq/L,</span> a serum glucose &gt;600 <span class=\"nowrap\">mg/dL</span> (33.3 <span class=\"nowrap\">mmol/L),</span> and test negative for ketones in serum and urine, although mild ketonemia may be present.</p><p/><p>Factors that contribute to the lesser degree of hyperglycemia in DKA, compared with HHS, are discussed elsewhere. (See <a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-epidemiology-and-pathogenesis#H7\" class=\"medical medical_review\">&quot;Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Epidemiology and pathogenesis&quot;, section on 'Hyperglycemia'</a>.)</p><p>Significant overlap between DKA and HHS has been reported in more than one-third of patients [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/1,4,16,68\" class=\"abstract_t\">1,4,16,68</a>].</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of hyperglycemic crises includes other causes of ketosis, acidosis, hyperosmolality, <span class=\"nowrap\">and/or</span> coma (<a href=\"image.htm?imageKey=ENDO%2F72299\" class=\"graphic graphic_table graphicRef72299 \">table 5</a>).</p><p class=\"headingAnchor\" id=\"H24\"><span class=\"h2\">Alcoholic and fasting ketoacidosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Alcoholic ketoacidosis (AKA) and starvation ketosis are other causes of ketoacidosis. Low carbohydrate diets can also precipitate ketoacidosis [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/69\" class=\"abstract_t\">69</a>]. The acidosis can be relatively severe in AKA. However, ketoacid levels with prolonged fasting ketoacidosis rarely exceed 8 to 10 <span class=\"nowrap\">mEq/L</span>. Therefore, the serum bicarbonate concentration is typically above 17 <span class=\"nowrap\">mEq/L</span> with uncomplicated fasting [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/70\" class=\"abstract_t\">70</a>]. More severe ketoacidosis may develop in fasting children and pregnant women [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/71,72\" class=\"abstract_t\">71,72</a>]. (See <a href=\"topic.htm?path=fasting-ketosis-and-alcoholic-ketoacidosis\" class=\"medical medical_review\">&quot;Fasting ketosis and alcoholic ketoacidosis&quot;</a>.)</p><p>Ketoacidosis without hyperglycemia in a patient with chronic alcoholism is virtually diagnostic of AKA. Modest elevations in serum glucose in patients with alcoholic ketoacidosis may reflect underlying unrecognized diabetes or a catecholamine-mediated stress response [<a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/73\" class=\"abstract_t\">73</a>]. Measurement of glycated hemoglobin (A1C) may help confirm chronic hyperglycemia.</p><p class=\"headingAnchor\" id=\"H25\"><span class=\"h2\">Anion gap acidosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Diabetic ketoacidosis (DKA) must be distinguished from other causes of high anion gap metabolic acidosis including lactic acidosis (which can rarely be induced by <a href=\"topic.htm?path=metformin-drug-information\" class=\"drug drug_general\">metformin</a>, particularly in patients with impaired renal function); <a href=\"topic.htm?path=aspirin-drug-information\" class=\"drug drug_general\">aspirin</a> or <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a> toxicity, and poisoning with methanol, ethylene glycol, and propylene glycol; D-lactic acidosis; and advanced chronic kidney disease (<a href=\"image.htm?imageKey=NEPH%2F77464\" class=\"graphic graphic_table graphicRef77464 \">table 6</a>). Although none of these disorders cause ketoacidosis (<a href=\"image.htm?imageKey=ENDO%2F72299\" class=\"graphic graphic_table graphicRef72299 \">table 5</a>), several causes of acidosis may coexist, especially lactic acid and ketoacidosis. (See <a href=\"topic.htm?path=approach-to-the-adult-with-metabolic-acidosis\" class=\"medical medical_review\">&quot;Approach to the adult with metabolic acidosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4566263\"><span class=\"h2\">Metabolic encephalopathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Toxic metabolic encephalopathy is usually a consequence of systemic illness, and its causes are diverse. In patients with diabetes, both severe hypoglycemia and severe hyperglycemia can result in coma. Measurement of fingerstick (capillary) or plasma glucose may be diagnostic (<a href=\"image.htm?imageKey=ENDO%2F72299\" class=\"graphic graphic_table graphicRef72299 \">table 5</a>). (See <a href=\"topic.htm?path=acute-toxic-metabolic-encephalopathy-in-adults\" class=\"medical medical_review\">&quot;Acute toxic-metabolic encephalopathy in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3370866680\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-hyperglycemic-emergencies\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Hyperglycemic emergencies&quot;</a>.)</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=diabetic-ketoacidosis-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Diabetic ketoacidosis (The Basics)&quot;</a> and <a href=\"topic.htm?path=hyperosmolar-nonketotic-coma-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Hyperosmolar nonketotic coma (The Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H26\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Although part of a spectrum of diabetic complications, diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) primarily differ according to the presence of ketoacidosis and the degree of hyperglycemia (<a href=\"image.htm?imageKey=ENDO%2F72111\" class=\"graphic graphic_table graphicRef72111 \">table 1</a>). (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A precipitating event can usually be identified in patients with DKA or HHS. The most common are infection (most often pneumonia or urinary tract infection) and discontinuation of or inadequate insulin therapy (<a href=\"image.htm?imageKey=PC%2F64374\" class=\"graphic graphic_table graphicRef64374 \">table 2</a>). (See <a href=\"#H3\" class=\"local\">'Precipitating factors'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Neurologic symptoms, which may include focal findings, are more often seen in HHS and primarily occur when the effective plasma osmolality is greater than 320 to 330 <span class=\"nowrap\">mosmol/kg</span>. The presence of stupor or coma in diabetic patients with an effective plasma osmolality below 320 <span class=\"nowrap\">mosmol/kg</span> demands immediate consideration of other causes of the mental status change. Abdominal pain is common in DKA but not in HHS, and requires evaluation if it does not resolve with treatment of the acidosis. Infection can occur without fever. (See <a href=\"#H4\" class=\"local\">'Clinical presentation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The initial evaluation of patients with hyperglycemic crises should include assessment of cardiorespiratory status, volume status, and mental status (<a href=\"image.htm?imageKey=EM%2F57723\" class=\"graphic graphic_table graphicRef57723 \">table 3</a>). The initial laboratory evaluation of a patient with suspected DKA or HHS should include determination of serum glucose, electrolytes (with calculation of the anion gap), blood urea nitrogen (BUN), and plasma creatinine, complete blood count (CBC) with differential, urinalysis and urine ketones by dipstick, plasma osmolality, serum ketones (if urine ketones are present), arterial blood gas (if the serum bicarbonate is substantially reduced or hypoxia is suspected), and electrocardiogram. (See <a href=\"#H6003656\" class=\"local\">'Diagnostic evaluation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Three ketone bodies are produced in DKA: one ketoacid (acetoacetic acid), one hydroxyacid (beta-hydroxybutyric acid), and one neutral ketone (acetone). Testing for serum ketones is generally performed if urine testing is positive. Urine ketone bodies are detected by a dipstick with <a href=\"topic.htm?path=nitroprusside-drug-information\" class=\"drug drug_general\">nitroprusside</a> tests, while serum ketones can be detected with either a nitroprusside test or by direct assay of beta-hydroxybutyrate levels. Direct assay of beta-hydroxybutyrate levels is preferred. (See <a href=\"#H12\" class=\"local\">'Serum ketones'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with DKA usually present with a serum anion gap greater than 20 <span class=\"nowrap\">mEq/L</span>. However, the increase in anion gap is variable, being determined by several factors: the rate and duration of ketoacid production, the rate of metabolism of the ketoacids and their loss in the urine, and the volume of distribution of the ketoacid anions. (See <a href=\"#H15\" class=\"local\">'Anion gap metabolic acidosis'</a> above and <a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-epidemiology-and-pathogenesis#H4633831\" class=\"medical medical_review\">&quot;Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Epidemiology and pathogenesis&quot;, section on 'Anion gap metabolic acidosis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Most patients with DKA and HHS are mildly hyponatremic, but patients who have a marked osmotic diuresis may have a normal or even elevated serum sodium concentration. The serum sodium concentration in DKA and HHS reflects the balance between the dilutional effect of water moving out of cells in response to the hyperglycemia-induced increase in serum osmolality and the increase in water excretion due to the glucosuria-induced osmotic diuresis (<a href=\"image.htm?imageKey=ENDO%2F76060\" class=\"graphic graphic_table graphicRef76060 \">table 4</a>). (See <a href=\"#H16\" class=\"local\">'Serum sodium'</a> above and <a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-epidemiology-and-pathogenesis#H4634824\" class=\"medical medical_review\">&quot;Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Epidemiology and pathogenesis&quot;, section on 'Plasma osmolality and sodium'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with DKA or HHS have a potassium deficit that averages 300 to 600 mEq. Despite this deficit, the serum potassium concentration is often elevated at presentation, as both insulin deficiency and hyperosmolality result in potassium movement out of the cells into the extracellular fluid (ECF). Insulin therapy lowers the potassium concentration and may cause severe hypokalemia, particularly in patients with a normal or low serum potassium concentration at presentation. Thus, careful monitoring and timely administration of potassium supplementation are essential. (See <a href=\"#H18\" class=\"local\">'Serum potassium'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serum amylase and lipase levels are elevated in 15 to 25 percent of patients with DKA and, in most cases, do not reflect acute pancreatitis. The diagnosis of pancreatitis should be based upon clinical findings and confirmed by imaging. (See <a href=\"#H20\" class=\"local\">'Serum amylase and lipase'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>DKA is diagnosed when the triad of hyperglycemia, anion gap metabolic acidosis, and ketonemia is present. Metabolic acidosis is often the major finding. The serum glucose concentration is usually less than 800 <span class=\"nowrap\">mg/dL</span> (44 <span class=\"nowrap\">mmol/L)</span> and often approximately 350 to 500 <span class=\"nowrap\">mg/dL</span> (19.4 to 27.8 <span class=\"nowrap\">mmol/L)</span>. In HHS, there is little or no ketoacid accumulation, the serum glucose concentration frequently exceeds 1000 <span class=\"nowrap\">mg/dL</span> (56 <span class=\"nowrap\">mmol/L),</span> the effective plasma osmolality is &gt;320 <span class=\"nowrap\">mosmol/kg,</span> and neurologic abnormalities are frequently present (including coma in 25 to 50 percent of cases) (<a href=\"image.htm?imageKey=ENDO%2F72111\" class=\"graphic graphic_table graphicRef72111 \">table 1</a>). (See <a href=\"#H5509770\" class=\"local\">'Diagnostic criteria'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ketoacidosis may also be caused by alcohol abuse or fasting. Other causes of an anion gap acidosis include lactic acidosis, ingestion of drugs such as <a href=\"topic.htm?path=aspirin-drug-information\" class=\"drug drug_general\">aspirin</a>, methanol, and ethylene glycol, and advanced chronic kidney disease. (See <a href=\"#H23\" class=\"local\">'Differential diagnosis'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H3347572822\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We are saddened by the death of Abbas Kitabchi, PhD, MD, FACP, MACE, who passed away in July 2016. UpToDate wishes to acknowledge Dr. Kitabchi's past work as an author for this topic.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li class=\"breakAll\">Kitabchi AE, Razavi L.Hyperglycemic Crises: Diabetic Ketoacidosis (DKA), And Hyperglycemic Hyperosmolar State (HHS). In: http://www.endotext.org/diabetes/diabetes24/diabetesframe24.htm (Accessed on January 30, 2013).</li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/2\" class=\"nounderline abstract_t\">Randall L, Begovic J, Hudson M, et al. Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors. Diabetes Care 2011; 34:1891.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/3\" class=\"nounderline abstract_t\">Wachtel TJ, Tetu-Mouradjian LM, Goldman DL, et al. Hyperosmolarity and acidosis in diabetes mellitus: a three-year experience in Rhode Island. J Gen Intern Med 1991; 6:495.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/4\" class=\"nounderline abstract_t\">Wachtel TJ. The diabetic hyperosmolar state. Clin Geriatr Med 1990; 6:797.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/5\" class=\"nounderline abstract_t\">Wachtel TJ, Silliman RA, Lamberton P. Prognostic factors in the diabetic hyperosmolar state. J Am Geriatr Soc 1987; 35:737.</a></li><li class=\"breakAll\">Kitabchi AE, Murphy MB. Consequences of insulin deficiency. In: Atlas of Diabetes, 4th, Skyler J (Ed), Springer US, New York 2012. p.39.</li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/7\" class=\"nounderline abstract_t\">Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005; 19 Suppl 1:1.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/8\" class=\"nounderline abstract_t\">Taylor SI, Blau JE, Rother KI. SGLT2 Inhibitors May Predispose to Ketoacidosis. J Clin Endocrinol Metab 2015; 100:2849.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/9\" class=\"nounderline abstract_t\">Warner EA, Greene GS, Buchsbaum MS, et al. Diabetic ketoacidosis associated with cocaine use. Arch Intern Med 1998; 158:1799.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/10\" class=\"nounderline abstract_t\">Nyenwe EA, Loganathan RS, Blum S, et al. Active use of cocaine: an independent risk factor for recurrent diabetic ketoacidosis in a city hospital. Endocr Pract 2007; 13:22.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/11\" class=\"nounderline abstract_t\">Polonsky WH, Anderson BJ, Lohrer PA, et al. Insulin omission in women with IDDM. Diabetes Care 1994; 17:1178.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/12\" class=\"nounderline abstract_t\">Peden NR, Braaten JT, McKendry JB. Diabetic ketoacidosis during long-term treatment with continuous subcutaneous insulin infusion. Diabetes Care 1984; 7:1.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/13\" class=\"nounderline abstract_t\">Pa&#324;kowska E, B&#322;azik M, Dziechciarz P, et al. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes 2009; 10:52.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/14\" class=\"nounderline abstract_t\">Daugirdas JT, Kronfol NO, Tzamaloukas AH, Ing TS. Hyperosmolar coma: cellular dehydration and the serum sodium concentration. Ann Intern Med 1989; 110:855.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/15\" class=\"nounderline abstract_t\">Fulop M, Tannenbaum H, Dreyer N. Ketotic hyperosmolar coma. Lancet 1973; 2:635.</a></li><li class=\"breakAll\">Kitabchi AE, Fisher JN. Insulin therapy of diabetic ketoacidosis: Physiologic versus pharmacologic doses of insulin and their routes of administration. In: Handbook of Diabetes Mellitus, Brownlee M (Ed), Garland ATPM Press, New York 1981. p.95.</li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/17\" class=\"nounderline abstract_t\">Lorber D. Nonketotic hypertonicity in diabetes mellitus. Med Clin North Am 1995; 79:39.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/18\" class=\"nounderline abstract_t\">Maccario M. Neurological dysfunction associated with nonketotic hyperglycemia. Arch Neurol 1968; 19:525.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/19\" class=\"nounderline abstract_t\">Guisado R, Arieff AI. Neurologic manifestations of diabetic comas: correlation with biochemical alterations in the brain. Metabolism 1975; 24:665.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/20\" class=\"nounderline abstract_t\">Lavin PJ. Hyperglycemic hemianopia: a reversible complication of non-ketotic hyperglycemia. Neurology 2005; 65:616.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/21\" class=\"nounderline abstract_t\">Harden CL, Rosenbaum DH, Daras M. Hyperglycemia presenting with occipital seizures. Epilepsia 1991; 32:215.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/22\" class=\"nounderline abstract_t\">Nyenwe EA, Razavi LN, Kitabchi AE, et al. Acidosis: the prime determinant of depressed sensorium in diabetic ketoacidosis. Diabetes Care 2010; 33:1837.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/23\" class=\"nounderline abstract_t\">Malone ML, Gennis V, Goodwin JS. Characteristics of diabetic ketoacidosis in older versus younger adults. J Am Geriatr Soc 1992; 40:1100.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/24\" class=\"nounderline abstract_t\">Umpierrez G, Freire AX. Abdominal pain in patients with hyperglycemic crises. J Crit Care 2002; 17:63.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/25\" class=\"nounderline abstract_t\">Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009; 32:1335.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/26\" class=\"nounderline abstract_t\">Barrett EJ, DeFronzo RA. Diabetic ketoacidosis: diagnosis and treatment. Hosp Pract (Off Ed) 1984; 19:89.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/27\" class=\"nounderline abstract_t\">Kitabchi AE, Umpierrez GE, Murphy MB, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care 2001; 24:131.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/28\" class=\"nounderline abstract_t\">Arieff AI, Carroll HJ. Nonketotic hyperosmolar coma with hyperglycemia: clinical features, pathophysiology, renal function, acid-base balance, plasma-cerebrospinal fluid equilibria and the effects of therapy in 37 cases. Medicine (Baltimore) 1972; 51:73.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/29\" class=\"nounderline abstract_t\">Munro JF, Campbell IW, McCuish AC, Duncan LJ. Euglycaemic diabetic ketoacidosis. Br Med J 1973; 2:578.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/30\" class=\"nounderline abstract_t\">Burge MR, Hardy KJ, Schade DS. Short-term fasting is a mechanism for the development of euglycemic ketoacidosis during periods of insulin deficiency. J Clin Endocrinol Metab 1993; 76:1192.</a></li><li class=\"breakAll\">Eisenbarth GS, Polonsky KS, Buse JB. Type 1 diabetes mellitus: Acute diabetic emergencies: Diabetic ketoacidosis. In: Williams Textbook of Endocrinology, Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (Eds), Elsevier Science, Philadelphia 2003. p.1500.</li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/32\" class=\"nounderline abstract_t\">Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 1999; 15:412.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/33\" class=\"nounderline abstract_t\">Sheikh-Ali M, Karon BS, Basu A, et al. Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care 2008; 31:643.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/34\" class=\"nounderline abstract_t\">Wiggam MI, O'Kane MJ, Harper R, et al. Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study. Diabetes Care 1997; 20:1347.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/35\" class=\"nounderline abstract_t\">Porter WH, Yao HH, Karounos DG. Laboratory and clinical evaluation of assays for beta-hydroxybutyrate. Am J Clin Pathol 1997; 107:353.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/36\" class=\"nounderline abstract_t\">Fulop M, Murthy V, Michilli A, et al. Serum beta-hydroxybutyrate measurement in patients with uncontrolled diabetes mellitus. Arch Intern Med 1999; 159:381.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/37\" class=\"nounderline abstract_t\">Smith SW, Manini AF, Szekely T, Hoffman RS. Bedside detection of urine beta-hydroxybutyrate in diagnosing metabolic acidosis. Acad Emerg Med 2008; 15:751.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/38\" class=\"nounderline abstract_t\">Bektas F, Eray O, Sari R, Akbas H. Point of care blood ketone testing of diabetic patients in the emergency department. Endocr Res 2004; 30:395.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/39\" class=\"nounderline abstract_t\">DeFronzo RA, Matzuda M, Barret E. Diabetic ketoacidosis: a combined metabolic-nephrologic approach to therapy. Diabetes Rev 1994; 2:209.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/40\" class=\"nounderline abstract_t\">Adrogu&eacute; HJ, Lederer ED, Suki WN, Eknoyan G. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore) 1986; 65:163.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/41\" class=\"nounderline abstract_t\">Khardori R, Soler NG. Hyperosmolar hyperglycemic nonketotic syndrome. Report of 22 cases and brief review. Am J Med 1984; 77:899.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/42\" class=\"nounderline abstract_t\">Phillips PA, Bretherton M, Johnston CI, Gray L. Reduced osmotic thirst in healthy elderly men. Am J Physiol 1991; 261:R166.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/43\" class=\"nounderline abstract_t\">Kaminska ES, Pourmotabbed G. Spurious laboratory values in diabetic ketoacidosis and hyperlipidemia. Am J Emerg Med 1993; 11:77.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/44\" class=\"nounderline abstract_t\">Rumbak MJ, Hughes TA, Kitabchi AE. Pseudonormoglycemia in diabetic ketoacidosis with elevated triglycerides. Am J Emerg Med 1991; 9:61.</a></li><li class=\"breakAll\">Emmett M. Case 6: Diabetes and Acidosis. In: NephSAP: Nephrology Self-Assessment Program: Fluid, Electrolyte, and Acid-Base Disturbances, Sterns RH, Emmett M (Eds), The American Society of Nephrology 2013. Vol 12, No 3, p.191.</li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/46\" class=\"nounderline abstract_t\">Graber ML, Quigg RJ, Stempsey WE, Weis S. Spurious hyperchloremia and decreased anion gap in hyperlipidemia. Ann Intern Med 1983; 98:607.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/47\" class=\"nounderline abstract_t\">Kreisberg RA. Diabetic ketoacidosis: new concepts and trends in pathogenesis and treatment. Ann Intern Med 1978; 88:681.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/48\" class=\"nounderline abstract_t\">Abramson E, Arky R. Diabetic acidosis with initial hypokalemia. Therapeutic implications. JAMA 1966; 196:401.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/49\" class=\"nounderline abstract_t\">Murthy K, Harrington JT, Siegel RD. Profound hypokalemia in diabetic ketoacidosis: a therapeutic challenge. Endocr Pract 2005; 11:331.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/50\" class=\"nounderline abstract_t\">Arora S, Cheng D, Wyler B, Menchine M. Prevalence of hypokalemia in ED patients with diabetic ketoacidosis. Am J Emerg Med 2012; 30:481.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/51\" class=\"nounderline abstract_t\">Atchley DW, Loeb RF, Richards DW, et al. ON DIABETIC ACIDOSIS: A Detailed Study of Electrolyte Balances Following the Withdrawal and Reestablishment of Insulin Therapy. J Clin Invest 1933; 12:297.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/52\" class=\"nounderline abstract_t\">Kebler R, McDonald FD, Cadnapaphornchai P. Dynamic changes in serum phosphorus levels in diabetic ketoacidosis. Am J Med 1985; 79:571.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/53\" class=\"nounderline abstract_t\">Shen T, Braude S. Changes in serum phosphate during treatment of diabetic ketoacidosis: predictive significance of severity of acidosis on presentation. Intern Med J 2012; 42:1347.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/54\" class=\"nounderline abstract_t\">Molitch ME, Rodman E, Hirsch CA, Dubinsky E. Spurious serum creatinine elevations in ketoacidosis. Ann Intern Med 1980; 93:280.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/55\" class=\"nounderline abstract_t\">Kemperman FA, Weber JA, Gorgels J, et al. The influence of ketoacids on plasma creatinine assays in diabetic ketoacidosis. J Intern Med 2000; 248:511.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/56\" class=\"nounderline abstract_t\">Yadav D, Nair S, Norkus EP, Pitchumoni CS. Nonspecific hyperamylasemia and hyperlipasemia in diabetic ketoacidosis: incidence and correlation with biochemical abnormalities. Am J Gastroenterol 2000; 95:3123.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/57\" class=\"nounderline abstract_t\">Warshaw AL, Feller ER, Lee KH. On the cause of raised serum-amylase in diabetic ketoacidosis. Lancet 1977; 1:929.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/58\" class=\"nounderline abstract_t\">Vinicor F, Lehrner LM, Karn RC, Merritt AD. Hyperamylasemia in diabetic ketoacidosis: sources and significance. Ann Intern Med 1979; 91:200.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/59\" class=\"nounderline abstract_t\">Vantyghem MC, Haye S, Balduyck M, et al. Changes in serum amylase, lipase and leukocyte elastase during diabetic ketoacidosis and poorly controlled diabetes. Acta Diabetol 1999; 36:39.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/60\" class=\"nounderline abstract_t\">Kjaergaard JJ, Salling N, Magid E, Ditzel J. Serum amylase during recovery from diabetic ketoacidosis. Diabete Metab 1984; 10:25.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/61\" class=\"nounderline abstract_t\">Nair S, Yadav D, Pitchumoni CS. Association of diabetic ketoacidosis and acute pancreatitis: observations in 100 consecutive episodes of DKA. Am J Gastroenterol 2000; 95:2795.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/62\" class=\"nounderline abstract_t\">Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 2004; 53:2079.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/63\" class=\"nounderline abstract_t\">Nematollahi LR, Taheri E, Larijani B, et al. Catecholamine-induced leukocytosis in acute hypoglycemic stress. J Investig Med 2007; 55:S262.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/64\" class=\"nounderline abstract_t\">Slovis CM, Mork VG, Slovis RJ, Bain RP. Diabetic ketoacidosis and infection: leukocyte count and differential as early predictors of serious infection. Am J Emerg Med 1987; 5:1.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/65\" class=\"nounderline abstract_t\">Weidman SW, Ragland JB, Fisher JN Jr, et al. Effects of insulin on plasma lipoproteins in diabetic ketoacidosis: evidence for a change in high density lipoprotein composition during treatment. J Lipid Res 1982; 23:171.</a></li><li class=\"breakAll\">Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th, McGraw-Hill, New York 2001. p.809-815.</li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/67\" class=\"nounderline abstract_t\">Morris LR, Kitabchi AE. Efficacy of low-dose insulin therapy for severely obtunded patients in diabetic ketoacidosis. Diabetes Care 1980; 3:53.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/68\" class=\"nounderline abstract_t\">Szeto CC, Li KY, Ko GT, et al. Acromegaly in a woman presenting with diabetic ketoacidosis and insulin resistance. Int J Clin Pract 1997; 51:476.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/69\" class=\"nounderline abstract_t\">Shah P, Isley WL. Ketoacidosis during a low-carbohydrate diet. N Engl J Med 2006; 354:97.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/70\" class=\"nounderline abstract_t\">Reichard GA Jr, Owen OE, Haff AC, et al. Ketone-body production and oxidation in fasting obese humans. J Clin Invest 1974; 53:508.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/71\" class=\"nounderline abstract_t\">Cahill GF Jr. Fuel metabolism in starvation. Annu Rev Nutr 2006; 26:1.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/72\" class=\"nounderline abstract_t\">Mahoney CA. Extreme gestational starvation ketoacidosis: case report and review of pathophysiology. Am J Kidney Dis 1992; 20:276.</a></li><li><a href=\"https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis/abstract/73\" class=\"nounderline abstract_t\">Wrenn KD, Slovis CM, Minion GE, Rutkowski R. The syndrome of alcoholic ketoacidosis. Am J Med 1991; 91:119.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 1792 Version 26.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H26\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">PRECIPITATING FACTORS</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">CLINICAL PRESENTATION</a><ul><li><a href=\"#H6\" id=\"outline-link-H6\">Neurologic symptoms</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Abdominal pain in DKA</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Physical examination</a></li></ul></li><li><a href=\"#H6003656\" id=\"outline-link-H6003656\">DIAGNOSTIC EVALUATION</a><ul><li><a href=\"#H6004079\" id=\"outline-link-H6004079\">Initial evaluation</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">Laboratory findings</a><ul><li><a href=\"#H11\" id=\"outline-link-H11\">- Serum glucose</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">- Serum ketones</a><ul><li><a href=\"#H3174363\" id=\"outline-link-H3174363\">Nitroprusside testing</a></li><li><a href=\"#H3174381\" id=\"outline-link-H3174381\">Direct measurement of serum beta-hydroxybutyrate</a></li></ul></li><li><a href=\"#H15\" id=\"outline-link-H15\">- Anion gap metabolic acidosis</a></li><li><a href=\"#H4564954\" id=\"outline-link-H4564954\">- Plasma osmolality</a></li><li><a href=\"#H16\" id=\"outline-link-H16\">- Serum sodium</a><ul><li><a href=\"#H17\" id=\"outline-link-H17\">Pseudohyponatremia/pseudohyperchloremia</a></li></ul></li><li><a href=\"#H18\" id=\"outline-link-H18\">- Serum potassium</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">- Serum phosphate</a></li><li><a href=\"#H3174624\" id=\"outline-link-H3174624\">- Serum creatinine</a></li><li><a href=\"#H20\" id=\"outline-link-H20\">- Serum amylase and lipase</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">- Leukocytosis</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">- Lipids</a></li></ul></li></ul></li><li><a href=\"#H5509770\" id=\"outline-link-H5509770\">DIAGNOSTIC CRITERIA</a></li><li><a href=\"#H23\" id=\"outline-link-H23\">DIFFERENTIAL DIAGNOSIS</a><ul><li><a href=\"#H24\" id=\"outline-link-H24\">Alcoholic and fasting ketoacidosis</a></li><li><a href=\"#H25\" id=\"outline-link-H25\">Anion gap acidosis</a></li><li><a href=\"#H4566263\" id=\"outline-link-H4566263\">Metabolic encephalopathy</a></li></ul></li><li><a href=\"#H3370866680\" id=\"outline-link-H3370866680\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H24146964\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H26\" id=\"outline-link-H26\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#H3347572822\" id=\"outline-link-H3347572822\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ENDO/1792|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ENDO/72111\" class=\"graphic graphic_table\">- Typical lab characteristics of DKA and HHS</a></li><li><a href=\"image.htm?imageKey=PC/64374\" class=\"graphic graphic_table\">- Precipitating factors DKA and HHS</a></li><li><a href=\"image.htm?imageKey=EM/57723\" class=\"graphic graphic_table\">- DKA rapid overview</a></li><li><a href=\"image.htm?imageKey=ENDO/76060\" class=\"graphic graphic_table\">- ADA DKA HHS water deficit</a></li><li><a href=\"image.htm?imageKey=ENDO/72299\" class=\"graphic graphic_table\">- Lab findings metabolic causes acidosis coma</a></li><li><a href=\"image.htm?imageKey=NEPH/77464\" class=\"graphic graphic_table\">- Causes of metabolic acidosis</a></li></ul></li></ul></div></div><div><h2>CALCULATORS</h2><div id=\"outlineCalculators\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=calculator-plasma-sodium-concentration-correction-for-hyperglycemia\" title=\"calculator 1\" class=\"calc calc_professional\">Calculator: Plasma sodium concentration correction for hyperglycemia</a></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-toxic-metabolic-encephalopathy-in-adults\" class=\"medical medical_review\">Acute toxic-metabolic encephalopathy in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-adult-with-metabolic-acidosis\" class=\"medical medical_review\">Approach to the adult with metabolic acidosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-diabetic-ketoacidosis-in-children-and-adolescents\" class=\"medical medical_review\">Clinical features and diagnosis of diabetic ketoacidosis in children and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-pancreatitis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of acute pancreatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-epidemiology-and-pathogenesis\" class=\"medical medical_review\">Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Epidemiology and pathogenesis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-treatment\" class=\"medical medical_review\">Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnostic-evaluation-of-adults-with-hyponatremia\" class=\"medical medical_review\">Diagnostic evaluation of adults with hyponatremia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=etiology-clinical-manifestations-and-diagnosis-of-volume-depletion-in-adults\" class=\"medical medical_review\">Etiology, clinical manifestations, and diagnosis of volume depletion in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=fasting-ketosis-and-alcoholic-ketoacidosis\" class=\"medical medical_review\">Fasting ketosis and alcoholic ketoacidosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diabetic-ketoacidosis-the-basics\" class=\"medical medical_basics\">Patient education: Diabetic ketoacidosis (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hyperosmolar-nonketotic-coma-the-basics\" class=\"medical medical_basics\">Patient education: Hyperosmolar nonketotic coma (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=serum-anion-gap-in-conditions-other-than-metabolic-acidosis\" class=\"medical medical_review\">Serum anion gap in conditions other than metabolic acidosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-hyperglycemic-emergencies\" class=\"medical medical_society_guidelines\">Society guideline links: Hyperglycemic emergencies</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=sodium-glucose-co-transporter-2-inhibitors-for-the-treatment-of-type-2-diabetes-mellitus\" class=\"medical medical_review\">Sodium-glucose co-transporter 2 inhibitors for the treatment of type 2 diabetes mellitus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-and-complications-of-diabetic-ketoacidosis-in-children-and-adolescents\" class=\"medical medical_review\">Treatment and complications of diabetic ketoacidosis in children and adolescents</a></li></ul></div></div>","javascript":null}